Lumara Analytics vs. Nexora, Clarivex, Vantrel • Q3 2024
| Competitor | Your CSAT | Competitor CSAT | Premium | Churn Risk Multiplier | Market Share | Win-Rate vs. | Status |
|---|---|---|---|---|---|---|---|
| Nexora (Leader) | 4.09 | 4.27 | -0.18 | 2.1x | 34% | 38% | At Risk |
| Clarivex | 4.09 | 3.98 | +0.11 | 0.8x | 19% | 64% | Advantage |
| Vantrel | 4.09 | 3.81 | +0.28 | 0.5x | 12% | 79% | Strong |
| Category Median | 4.09 | 3.92 | +0.17 | — | — | — | Above Avg |